Stock listing
NASDAQ:HOOK Hookipa Pharma Inc Stock
Follow Hookipa Pharma Inc into a list and get an email when it puts out news.
Delisted NASDAQ:HOOK no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:HOOK
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Hookipa Pharma Inc on 6ix
- Calls
- 3 calls with a replay · 3 with a transcript · latest Mar 15, 2023
- Decks
- 3 decks · latest Jan 2, 2025
Events
| Call | When | Status |
|---|---|---|
| HOOKIPA Pharma (HOOK) Q4 2022 Earnings Call | Wed, Mar 15, 2023 · 8:30 AM ET | Replay |
| HOOKIPA Pharma (HOOK) Q4 2021 Earnings Call | Thu, Mar 24, 2022 · 8:30 AM ET | Replay |
| HOOKIPA Pharma (HOOK) Q1 2021 Earnings Call | Wed, May 12, 2021 | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (January 2025) | Merger or acquisition | 44 slides | Jan 2, 2025 |
| Corporate Update (December 2020) | Corporate update | 22 slides | Dec 7, 2020 |
| Technical Presentation (November 2020) | Technical | 14 slides | Nov 30, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Michael A. Kelly Other companies: Prime Medicine, Inc. (Board Member · Since at least Oct 19, 2022); Amicus Therapeutics Inc (Director · Since at least Dec 1, 2020); DMC Global Inc. (Director · Since at least Jul 24, 2020); NeoGenomics, Inc. (Board Member · Since at least Jul 15, 2020); Aprea Therapeutics, Inc. (Director · Sep 28, 2020 – Jun 30, 2021 · Past) | Director · Apr 17, 2019 – Jun 30, 2022 · Past |
| Igor Matushansky Other companies: Immuneering Corporation (Chief Medical Officer · Since at least Mar 17, 2025) | Chief Medical Officer · Apr 17, 2019 – Jun 30, 2022 · Past |
| Jorn Aldag Other companies: Cogent Biosciences, Inc. (Director · Mar 28, 2018 – Jul 1, 2020 · Past) | Chief Executive Officer, Director · Apr 17, 2019 – Apr 15, 2024 · Past |
| Anders Lilja | Sr. VP, Technical Development · Apr 17, 2019 – Jan 23, 2020 · Past |
| David Pinschewer | Chief Scientific Officer · Apr 17, 2019 – Apr 17, 2019 · Past |
| Mark Winderlich | Chief Development Officer · Apr 1, 2024 – Apr 15, 2024 · Past |
Log in to ask 6ix AI your own questions about Hookipa Pharma Inc.